Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma
出版年份 2021 全文链接
标题
Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma
作者
关键词
hepatocellular carcinoma, ginsenoside Rg3, ganoderma lucidum polysaccharide, oridonin, epidermal growth factor receptor
出版物
Molecular Therapy-Oncolytics
Volume 22, Issue -, Pages 604-616
出版商
Elsevier BV
发表日期
2021-08-19
DOI
10.1016/j.omto.2021.08.008
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Solubility and Bioavailability Enhancement of Oridonin: A Review
- (2020) Yuanyuan Zhang et al. MOLECULES
- Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
- (2020) Eunus S. Ali et al. SEMINARS IN CANCER BIOLOGY
- HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
- (2020) Natthaporn Sueangoen et al. Cell and Bioscience
- The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance
- (2020) Cristina P. R. Xavier et al. Cells
- The Impact of the Cancer Microenvironment on Macrophage Phenotypes
- (2020) Sunyoung Ham et al. Frontiers in Immunology
- Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells
- (2020) Ning Kang et al. TOXICOLOGY IN VITRO
- Programmable Delivery of Synergistic Cancer Drug Combinations Using Bicompartmental Nanoparticles
- (2020) Jason V. Gregory et al. Advanced Healthcare Materials
- Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
- (2020) Yuxiao Song et al. Frontiers in Immunology
- Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
- (2020) Hwa-Yong Lee et al. Cancers
- The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
- (2020) Atsushi Tanabe et al. Cancers
- Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
- (2020) Alison L Raybould et al. Journal of Hepatocellular Carcinoma
- Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges
- (2020) Xin Gao et al. BIOMATERIALS
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
- (2019) Dai-Min Xiang et al. GUT
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- VEGF Impairs the Motility and Immune Function of Human Mature Dendritic Cells through VEGFR 2‐RhoA‐Cofilin1 Pathway
- (2019) Jinhua Long et al. CANCER SCIENCE
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
- (2019) Vaishali Aggarwal et al. Biomolecules
- Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
- (2019) Yoshie Kobayashi et al. SEMINARS IN CANCER BIOLOGY
- Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection
- (2018) Jimin Xu et al. MOLECULES
- The dark side of tumor-associated endothelial cells
- (2018) Francesco De Sanctis et al. SEMINARS IN IMMUNOLOGY
- Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
- (2018) Qirui Wang et al. Nature Communications
- Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
- (2018) Chuan Xing Wu et al. Theranostics
- Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
- (2018) Onat Kadioglu et al. Frontiers in Pharmacology
- Ganoderma lucidum Polysaccharides as An Anti-cancer Agent
- (2018) Didem Sohretoglu et al. Anti-Cancer Agents in Medicinal Chemistry
- Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
- (2018) Martina Da Ros et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma
- (2018) Courtney S. Malo et al. Frontiers in Oncology
- Successful development of oral SEDDS: screening of excipients from the industrial point of view
- (2018) Isabelle Nardin et al. ADVANCED DRUG DELIVERY REVIEWS
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Human monocytes and macrophages regulate immune tolerance via integrin αvβ8–mediated TGFβ activation
- (2018) Aoife Kelly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anticancer effects of ginsenoside Rg3 (Review)
- (2017) Mengyao Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Ganoderma
- (2016) Nebojša V. Kladar et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Discovery and development of natural product oridonin-inspired anticancer agents
- (2016) Ye Ding et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- Advanced research on vasculogenic mimicry in cancer
- (2015) Lili Qiao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
- (2015) Manuel Hidalgo et al. PANCREATOLOGY
- Key autophagic targets and relevant small-molecule compounds in cancer therapy
- (2014) X.-P Tong et al. CELL PROLIFERATION
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
- (2014) Fabrice André et al. LANCET ONCOLOGY
- The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
- (2014) Sandra S. McAllister et al. NATURE CELL BIOLOGY
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
- (2013) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility
- (2013) Chunyong Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway
- (2012) Yuan-chao Ye et al. ACTA PHARMACOLOGICA SINICA
- Oridonin: targeting programmed cell death pathways as an anti-tumour agent
- (2012) Z. Liu et al. CELL PROLIFERATION
- Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
- (2012) Priyambada Parhi et al. DRUG DISCOVERY TODAY
- Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: A 26-week intramuscular repeated administration study in rats
- (2012) J.-P. Liu et al. FOOD AND CHEMICAL TOXICOLOGY
- The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells
- (2012) Hiu-Yee Kwan et al. JOURNAL OF GASTROENTEROLOGY
- Antitumor and Immunomodulatory Effects of Polysaccharides from Broken-Spore of Ganoderma lucidum
- (2012) Peng-Yun Wang et al. Frontiers in Pharmacology
- Egfl7 Promotes Tumor Escape from Immunity by Repressing Endothelial Cell Activation
- (2011) S. Delfortrie et al. CANCER RESEARCH
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hepatocellular carcinoma: Epidemiology and clinical aspects
- (2007) Roberto Mazzanti et al. MOLECULAR ASPECTS OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started